Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

Ocular surface inflammation in conjunctival biopsies of patients with moderate to severe keratodonjunctivitis sicca before and after treatment with Topical Cyclosporin A

Go back to Resources

Ocular surface inflammation in conjunctival biopsies of patients with moderate to severe keratodonjunctivitis sicca before and after treatment with Topical Cyclosporin A

Authors:

Location:

Go back to Resources

The Advanced Glaucoma Intervention Study (AGIS): 8. Risk of cataract formation after trabeculectomy

Go back to Resources

The Advanced Glaucoma Intervention Study (AGIS): 8. Risk of cataract formation after trabeculectomy

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

The Advanced Glaucoma Intervention Study (AGIS) 10: Variability among academic glaucoma subspecialists in assessing optic disc notching

Go back to Resources

The Advanced Glaucoma Intervention Study (AGIS) 10: Variability among academic glaucoma subspecialists in assessing optic disc notching

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Tacrolimus vs. Cyclosporine as primary immunosuppression in pediatric renal transplant patients: a North American Pediatric Renal Cooperative Study (NAPRTCS) Report

Go back to Resources

Tacrolimus vs. Cyclosporine as primary immunosuppression in pediatric renal transplant patients: a North American Pediatric Renal Cooperative Study (NAPRTCS) Report

Authors:

Location:

Go back to Resources

Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) +/- antibody induction in simultaneous pancreas kidney (SPK) transplantation: one year results

Go back to Resources

Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) +/- antibody induction in simultaneous pancreas kidney (SPK) transplantation: one year results

Authors:

Location:

Go back to Resources

Synagis® (Palivizumab) Prophylaxis of Respiratory Syncytial Virus (RSV) Infection - Patient Dempgraphics and Preliminary Results from 2000-2001 Synagis® Outcomes Registry

Go back to Resources

Synagis® (Palivizumab) Prophylaxis of Respiratory Syncytial Virus (RSV) Infection - Patient Dempgraphics and Preliminary Results from 2000-2001 Synagis® Outcomes Registry

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Synagisâ (Palivizumab) prophylaxis of respiratory syncytial virus (RSV) infection - patient demographics and preliminary results from the 2000-2001 SynagisÒ Outcomes Registry

Go back to Resources

Synagisâ (Palivizumab) prophylaxis of respiratory syncytial virus (RSV) infection - patient demographics and preliminary results from the 2000-2001 SynagisÒ Outcomes Registry

Authors:

Location:

Go back to Resources

Studies in pediatric liver transplantation (SPLIT): Year 2000 outcomes

Go back to Resources

Studies in pediatric liver transplantation (SPLIT): Year 2000 outcomes

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Severity of RSV LRI hospitalizations in 33 to 35 week and 36 week gestational age infants

Go back to Resources

Severity of RSV LRI hospitalizations in 33 to 35 week and 36 week gestational age infants

Authors:

Location:

Go back to Resources

Safety and Immunogenicity of a Recombinant Hemagglutinin Vaccine for H5 Influenza in Humans

Go back to Resources

Safety and Immunogenicity of a Recombinant Hemagglutinin Vaccine for H5 Influenza in Humans

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 127
  • Page 128
  • Page 129
  • Page 130
  • Current page 131
  • Page 132
  • Page 133
  • Page 134
  • Page 135
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions
  • ISO Certification